Cargando…

Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome

OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yun, Ni, Jun, Xiong, Yali, Wu, Chao, He, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898529/
https://www.ncbi.nlm.nih.gov/pubmed/35249544
http://dx.doi.org/10.1186/s12879-022-07206-8
_version_ 1784663672880103424
author Liu, Yun
Ni, Jun
Xiong, Yali
Wu, Chao
He, Fei
author_facet Liu, Yun
Ni, Jun
Xiong, Yali
Wu, Chao
He, Fei
author_sort Liu, Yun
collection PubMed
description OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30, 2021. Univariate and multivariable Cox proportional hazards regression models were used to investigate the prognostic factors associated with 28-day mortality. Kaplan–Meier curves were analysed in patients stratified by the optimal cut-off point of the NLR determined using a receiver operating characteristic (ROC) curve. RESULTS: In total, 182 SFTS patients were included, and 24 (13.2%) died within 28 days. The median age of the included patients was 59.64 ± 12.74 years, and 48.4% (88/182) were male. The patients in the non-survival group had significantly higher NLRs than those in the survival group (6.91 ± 6.73 vs. 2.23 ± 1.83). The NLR was a significant predictor of 28-day mortality (adjusted HR: 1.121, 95% CI: 1.033, 1.215). The area under the ROC curve of the NLR for predicting 28-day mortality was 0.743 (95% CI: 0.624, 0.862), and the optimal cut-off value was 4.19 (sensitivity, 54.2%; specificity, 89.2%). In addition, 28-day mortality in the patients with an NLR ≥ 4.19 was notably higher than that in the patients with an NLR < 4.19 (43.3% vs. 7.2%), and Kaplan–Meier analysis showed that the patients with an NLR ≥ 4.19 had a significantly lower survival rate than those with an NLR < 4.19. CONCLUSIONS: The NLR was a significant, independent predictor of 28-day mortality in SFTS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07206-8.
format Online
Article
Text
id pubmed-8898529
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88985292022-03-17 Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome Liu, Yun Ni, Jun Xiong, Yali Wu, Chao He, Fei BMC Infect Dis Research OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30, 2021. Univariate and multivariable Cox proportional hazards regression models were used to investigate the prognostic factors associated with 28-day mortality. Kaplan–Meier curves were analysed in patients stratified by the optimal cut-off point of the NLR determined using a receiver operating characteristic (ROC) curve. RESULTS: In total, 182 SFTS patients were included, and 24 (13.2%) died within 28 days. The median age of the included patients was 59.64 ± 12.74 years, and 48.4% (88/182) were male. The patients in the non-survival group had significantly higher NLRs than those in the survival group (6.91 ± 6.73 vs. 2.23 ± 1.83). The NLR was a significant predictor of 28-day mortality (adjusted HR: 1.121, 95% CI: 1.033, 1.215). The area under the ROC curve of the NLR for predicting 28-day mortality was 0.743 (95% CI: 0.624, 0.862), and the optimal cut-off value was 4.19 (sensitivity, 54.2%; specificity, 89.2%). In addition, 28-day mortality in the patients with an NLR ≥ 4.19 was notably higher than that in the patients with an NLR < 4.19 (43.3% vs. 7.2%), and Kaplan–Meier analysis showed that the patients with an NLR ≥ 4.19 had a significantly lower survival rate than those with an NLR < 4.19. CONCLUSIONS: The NLR was a significant, independent predictor of 28-day mortality in SFTS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07206-8. BioMed Central 2022-03-06 /pmc/articles/PMC8898529/ /pubmed/35249544 http://dx.doi.org/10.1186/s12879-022-07206-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Yun
Ni, Jun
Xiong, Yali
Wu, Chao
He, Fei
Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title_full Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title_fullStr Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title_full_unstemmed Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title_short Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
title_sort neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898529/
https://www.ncbi.nlm.nih.gov/pubmed/35249544
http://dx.doi.org/10.1186/s12879-022-07206-8
work_keys_str_mv AT liuyun neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome
AT nijun neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome
AT xiongyali neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome
AT wuchao neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome
AT hefei neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome